Company / Net Debt per Share
Thermo Fisher Scientific Net Debt per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$75.57
FY2025
5-year range
$64.55 / $75.57
FY2021-FY2025
Trend
+10.0%
vs FY2024
Sector context
#5 of 98
Health Care
What the data says
Among 98 Health Care companies, Thermo Fisher Scientific is in the bottom 5% for net debt per share. Net Debt per Share has increased for 3 consecutive years, from $64.55 in FY2022 to $75.57 in FY2025.
Based on SEC 10-K filings.
75.57 in FY2025 with a 5-year CAGR of +21.9%. Top quartile in the Health Care sector.
Increased from $67.13 to $75.57 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- +5.4%
- 5-Year CAGR
- +21.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 98This company $75.57 Sector average $7.39
▼
+922.6% above sector average
Key checks
Key Insights
- Thermo Fisher Scientific's net debt per share has grown for 3 consecutive years.
- In FY2025, net debt per share increased 10.0% year-over-year.
- Ranks #5 out of 98 companies in the Health Care sector.
- Lowest net debt per share in the period was in FY2020.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $75.57 | +10.0% |
| FY2024 | $68.69 | +2.3% |
| FY2023 | $67.13 | +4.0% |
| FY2022 | $64.55 | -13.8% |
| FY2021 | $74.92 | +166.8% |
| FY2020 | $28.09 | -27.2% |
| FY2019 | $38.58 | -9.3% |
| FY2018 | $42.54 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026